Medical devices, healthcare technology and the business of care
510(k) clearance · K260990

Model 7000 Spirotrac

Vitalograph , Ltd. · Decision date Nov 4, 2026

MEDTECHLEDGER EXPLANATIONK260990

What did the FDA decide?

FDA recorded a substantially equivalent decision for Model 7000 Spirotrac, submitted by Vitalograph, Ltd. under 510(k) number K260990. The decision is dated 2026-11-04 and appears in the agency's list of 510(k) final decisions rendered since October 01, 2026. Substantially equivalent in this context denotes 510(k) clearance rather than premarket approval. The record lists the specialty as Anesthesiology and the product code as BZG.

The source data identify the device only by name and do not describe its components, intended use, or any changed item, and no predicate device or comparison is given. The application relationship is limited to the clearance itself: K260990 is the 510(k) submission for Model 7000 Spirotrac, and the listed applicant is Vitalograph, Ltd. No summary or statement is available in the public information, so the basis for the equivalence determination remains unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Nov 4, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260990
Regulatory pathway
510(k) premarket notification
Product code
BZG
Decision code
SESE
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Spirometer, Diagnostic.

Product code
BZG
FDA device class
2

FDA decision timeline

  1. K260990 received

    Application receipt date recorded by FDA.

  2. K260990 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Vitalograph , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ennis Co. Clare

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records